Viatris Inc. (VTRS)
NASDAQ: VTRS · Real-Time Price · USD
10.55
-0.11 (-0.99%)
At close: Aug 25, 2025, 4:00 PM
10.55
+0.01 (0.05%)
After-hours: Aug 25, 2025, 4:20 PM EDT
Viatris Market Cap
Viatris has a market cap or net worth of $12.29 billion as of August 25, 2025. Its market cap has decreased by -9.11% in one year.
Market Cap
12.29B
Enterprise Value
26.23B
1-Year Change
-9.11%
Ranking
Category
Stock Price
$10.55
Market Cap Chart
Since May 15, 1984, Viatris's market cap has increased from $146.99M to $12.29B, an increase of 8,264.01%. That is a compound annual growth rate of 11.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 22, 2025 | 12.42B | -16.44% |
| Dec 31, 2024 | 14.86B | 14.38% |
| Dec 29, 2023 | 12.99B | -3.74% |
| Dec 30, 2022 | 13.50B | -17.51% |
| Dec 31, 2021 | 16.36B | -27.24% |
| Dec 31, 2020 | 22.49B | 116.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 638.90B |
| Johnson & Johnson | 431.79B |
| AbbVie | 372.04B |
| UnitedHealth Group | 278.42B |
| Novo Nordisk | 253.97B |
| AstraZeneca | 251.25B |
| Novartis AG | 246.51B |
| Abbott Laboratories | 230.77B |